Table 2.
Different cell delivery methods for the regeneration of target organs
Approach | Advantage | Limitation | Ref |
---|---|---|---|
Scaffolds | • Carrying cells • Delivery pro-angiogenic factors • Providing 3D condition • Having stability |
• Timely degradation • Toxicity • Immune-modulatory effects |
[127–130] |
Stem cell priming or pretreatment | • Improve differentiation rate • Improve migration and homing rate to target tissue • Improve cell function |
• Cellular senescence • Critical consideration for cell treatment |
[131–136] |
Exosomes | • Bio-shuttle for pro- and anti-angiogenic factors • Lack of immune-privileged capacity |
• Promotes tumorgenesis • Needs to isolate and concentrated |
[137–142] |
Magnetic enhancement techniques | • Facilitate the cell retention rate • Control cells mobilization into target sites • Track transplanted cells in in vivo |
• Provide micro-emboli for cells with small size features | [143–145] |
Ultrasound techniques | • Enhance delivery of cells to target sites | • Yields cytotoxicity by promoting necrosis or apoptosis • Tissue damage such as arrhythmias, endothelium malfunction such as capillary leakage |
[146–148] |
Enhanced homing technique | • Enhance proliferating, migrating, and alignment of EPCs to target sites | ND* | [146, 149] |
Mannitol-enhanced delivery | • Used for cell delivery through the blood-brain barrier | • Being selective for distinct cells and factors | [48, 150–152] |
*Not fully determined